Sanofi Pasteur Partners with Immune Design in Race to Develop First HSV-2 Vaccine
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 11 (Table of Contents)
Published: 4 Nov-2014
DOI: 10.3833/pdr.v2014.i11.2072 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Sanofi Pasteur and US biotech Immune Design have agreed to pool assets in a collaboration aimed at developing a best-in-class herpes simplex virus-2 (HSV-2) vaccine...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS